[go: up one dir, main page]

WO2002004600A3 - Novel compounds - Google Patents

Novel compounds Download PDF

Info

Publication number
WO2002004600A3
WO2002004600A3 PCT/US2001/021985 US0121985W WO0204600A3 WO 2002004600 A3 WO2002004600 A3 WO 2002004600A3 US 0121985 W US0121985 W US 0121985W WO 0204600 A3 WO0204600 A3 WO 0204600A3
Authority
WO
WIPO (PCT)
Prior art keywords
novel compounds
polypeptides
polynucleotides
disclosed
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/021985
Other languages
French (fr)
Other versions
WO2002004600A2 (en
Inventor
Pankaj Agarwal
John P Cogswell
Ying-Ta Lai
Shelby A Martensen
Safia K Rizvi
Jay C Strum
Randall F Smith
Zhaoying Xiang
Qing Xie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Glaxo Group Ltd
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Ltd
Glaxo Group Ltd
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd, Glaxo Group Ltd, SmithKline Beecham Corp filed Critical SmithKline Beecham Ltd
Priority to AU2001276890A priority Critical patent/AU2001276890A1/en
Priority to US10/332,947 priority patent/US20040092713A1/en
Priority to EP01954662A priority patent/EP1299530A4/en
Priority to JP2002509455A priority patent/JP2004502453A/en
Publication of WO2002004600A2 publication Critical patent/WO2002004600A2/en
Publication of WO2002004600A3 publication Critical patent/WO2002004600A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Polypeptides and polynucleotides of the genes set forth in Table I and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing polypeptides and polynucleotides of the genes set forth in Table I in diagnostic assays.
PCT/US2001/021985 2000-07-12 2001-07-12 Novel compounds Ceased WO2002004600A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2001276890A AU2001276890A1 (en) 2000-07-12 2001-07-12 Novel compounds
US10/332,947 US20040092713A1 (en) 2001-07-12 2001-07-12 Novel compounds
EP01954662A EP1299530A4 (en) 2000-07-12 2001-07-12 Novel compounds
JP2002509455A JP2004502453A (en) 2000-07-12 2001-07-12 New compound

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21803300P 2000-07-12 2000-07-12
US60/218,033 2000-07-12
US22651700P 2000-08-21 2000-08-21
US60/226,517 2000-08-21

Publications (2)

Publication Number Publication Date
WO2002004600A2 WO2002004600A2 (en) 2002-01-17
WO2002004600A3 true WO2002004600A3 (en) 2002-06-20

Family

ID=26912504

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/021985 Ceased WO2002004600A2 (en) 2000-07-12 2001-07-12 Novel compounds

Country Status (4)

Country Link
EP (1) EP1299530A4 (en)
JP (1) JP2004502453A (en)
AU (1) AU2001276890A1 (en)
WO (1) WO2002004600A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1339845A2 (en) 2000-12-07 2003-09-03 ZymoGenetics, Inc. Adipocyte complemented related protein zacrp3x2
AU2002250143A1 (en) * 2001-03-16 2002-10-03 Eli Lilly And Company Lp mammalian proteins; related reagents
WO2003082915A2 (en) * 2002-03-29 2003-10-09 Genset Sa Xcrf polynucleotides and polypeptides and uses thereof
EP1869207A1 (en) * 2005-04-07 2007-12-26 AstraZeneca AB METHOD FOR ASSESSING THE PRESDISPOSITION AND/OR SUSCEPTIBILITY TO COPD BY ANALYSING FGF-BPl
GB0508863D0 (en) * 2005-04-29 2005-06-08 Astrazeneca Ab Peptide
EP3257953B1 (en) * 2009-03-12 2018-09-26 Cancer Prevention And Cure, Ltd. Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
AM. J. HUN. GENET., vol. 68, no. 2, 15 March 2001 (2001-03-15), pages 3325 - 3333 *
DATABASE GENCORE LOCUS [online] 1 June 1998 (1998-06-01), DYTRYCH ET AL., XP002946192, Database accession no. O55103 *
DATABASE GENCORE LOCUS [online] 1 March 2001 (2001-03-01), NAGASE ET AL.: "Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clone from brain which code for large proteins in vitro", XP002946191, Database accession no. Q9HCF2 *
DATABASE GENCORE LOCUS [online] BOERKOEL ET AL.: "Periaxiun mutations cause recessive dejerine-scottas neuropathy", XP002946189, Database accession no. AF321191 *
DATABASE GENCORE LOCUS [online] DOE JOINT GENOME INSTITUTE; September 1999 (1999-09-01), XP002946190, Database accession no. AC010271 *
DNA RES., vol. 7, 2000, pages 273 - 281 *
See also references of EP1299530A4 *

Also Published As

Publication number Publication date
AU2001276890A1 (en) 2002-01-21
EP1299530A4 (en) 2005-03-09
JP2004502453A (en) 2004-01-29
EP1299530A2 (en) 2003-04-09
WO2002004600A2 (en) 2002-01-17

Similar Documents

Publication Publication Date Title
HK1053840A1 (en) Novel compounds
WO2001066690A3 (en) Novel compounds
MXPA03000227A (en) Novel compounds.
WO2001072961A3 (en) Novel compounds
EP0939124A3 (en) MGBP1 sequences
WO2001004141A3 (en) Seripancrin
WO2002004600A3 (en) Novel compounds
EP0879888A3 (en) Patched-2 polypeptides and polynucleotides and methods for their production
WO2002008253A3 (en) A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY
WO2001083744A3 (en) Natrium-calcium exchanger protein
EP0943684A3 (en) Frizzled-like polypeptides and polynucleotides
WO2001032864A3 (en) Gpcr-kd5 polypeptides and dna sequences thereof
EP0887416A3 (en) Human AFC1
WO2002014355A3 (en) Novel mitogen activated kinase
WO2001083768A3 (en) Serine-threonine kinase
EP0890646A3 (en) HE2NW40 Serine Protease
EP0937777A3 (en) GABA receptors and their uses
WO2001083771A3 (en) Human phospholipase c delta 5
WO2001068816A8 (en) Human histamine h3 gene variant-3
WO2001062779A3 (en) New transcription factor carp-2
WO2001085921A3 (en) Human serine-threonine kinase-4
WO2001077150A3 (en) Serine-threonine kinase
WO2001072963A3 (en) Novel human uridine kinase
WO2001029178A3 (en) Epo primary response gene 1, eprg1
WO2001079269A3 (en) Lipid binding protein 4

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 2001954662

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001954662

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10332947

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2001954662

Country of ref document: EP